PSA Screening Results: How It Works, Results and What to Expect

PSA screening results measure prostate-specific antigen, a protein made by prostate cells, in a blood sample. A higher PSA result does not diagnose prostate cancer on its own; it is one factor a clinician uses alongside age, symptoms, prostate examination findings, PSA trends and, when appropriate, imaging or biopsy results.

PSA Screening Results: What They Mean

PSA screening results report the amount of prostate-specific antigen (PSA) in the blood, usually in nanograms per millilitre (ng/mL). PSA is produced by normal prostate tissue as well as by prostate conditions, so the test is not a direct test for cancer. It is best understood as a screening and risk-assessment tool rather than a diagnosis.

A result may be lower, higher or changing over time. Clinicians interpret it in context, considering a person’s age, family history, ethnicity, urinary symptoms, medications, prostate examination and previous PSA results. A result above a laboratory reference range may lead to repeat testing or further assessment, but many people with raised PSA do not have prostate cancer.

PSA testing is generally offered after an informed discussion of potential benefits and limitations. Screening may help identify some prostate cancers before symptoms develop, but it can also find slow-growing cancers that might never cause harm and may lead to additional tests, worry or treatment. The decision is individual and should be made with a qualified clinician.

How the PSA Test Works and Who May Consider It

The PSA test is a simple blood test. A healthcare professional takes a small blood sample from a vein in the arm, and a laboratory measures the PSA concentration. It does not require an injection into the prostate, sedation or a hospital stay.

People may consider PSA screening after discussing it with a doctor, particularly from middle age onward. Earlier or more individualized discussion may be appropriate for those with a close relative diagnosed with prostate cancer, certain inherited cancer-risk variants, or other factors that increase risk. Recommendations vary between countries and professional organizations, so personal health circumstances matter.

PSA may also be ordered when a person has urinary symptoms or an abnormal prostate examination. However, urinary difficulties are often caused by non-cancer conditions such as benign prostatic hyperplasia, also called prostate enlargement. A clinician can explain whether PSA testing is useful in a particular situation.

Preparing for the Test and What Happens Step by Step

Before the appointment, the clinician should be told about all medicines, supplements, recent illnesses and previous prostate procedures. Drugs that lower PSA, including certain medicines used for prostate enlargement, can affect interpretation. Do not stop prescribed medication unless the prescribing clinician specifically advises it.

During the procedure, a healthcare professional confirms identity details, applies a tourniquet to the upper arm, cleans the skin and takes the blood sample. The collection itself generally takes only a few minutes. Mild brief discomfort, bruising or light-headedness can occur with any blood draw, but serious problems are uncommon.

Afterward, normal activities can usually resume immediately. Results may be available within several days, depending on the laboratory and healthcare setting. If the PSA is unexpectedly raised, clinicians often repeat the test after avoiding temporary influences or after treating a possible infection, rather than making conclusions from one measurement alone.

What must you not do before a PSA test?

People are commonly advised to avoid ejaculation for about 48 hours before a PSA blood test because it may temporarily increase PSA. It may also be sensible to avoid vigorous cycling or activities that put prolonged pressure on the prostate for roughly 48 hours, although advice can vary. A PSA test may need to be delayed after a urinary infection, catheterization, prostate procedure or biopsy because these can affect the result; the clinician can advise on the appropriate timing.

How to Read PSA Levels and Age-Related Ranges

There is no PSA number that proves a person is healthy or that confirms prostate cancer. Historically, 4.0 ng/mL was often used as a general threshold for additional assessment, but modern interpretation is more nuanced. Some cancers occur at PSA values below 4.0 ng/mL, while many people with values above it have a non-cancer cause.

Age-related reference ranges may be used because PSA tends to rise gradually as the prostate enlarges with age. Approximate upper reference values sometimes used are around 2.5 ng/mL for ages 40 to 49, 3.5 ng/mL for ages 50 to 59, 4.5 ng/mL for ages 60 to 69 and 6.5 ng/mL for ages 70 to 79. These are not universal cutoffs and should not replace clinical interpretation.

What is a normal PSA score by age?

A normal PSA score by age is not a fixed rule. Many clinicians use age-adjusted ranges as a guide, but the most useful assessment compares the result with previous levels and the person’s overall risk profile. A result within an age-related range can still require review if it rises quickly or if there are concerning examination findings.

What is an average PSA score for a 70 year old?

PSA values vary widely among healthy 70-year-olds because prostate size and health history differ. Some age-adjusted references consider a PSA up to approximately 6.5 ng/mL within an expected range for people aged 70 to 79, but this is not necessarily an “average” or a guarantee that no cancer is present. A clinician should assess the trend, symptoms, medicines and personal risk factors before deciding on next steps.

Why PSA Can Be High or Low

PSA can rise for several reasons other than cancer. Benign prostate enlargement is common with age and can increase PSA. Prostate inflammation, known as prostatitis, and urinary tract infections may also cause a temporary or more marked increase.

Recent ejaculation, cycling, urinary retention, catheter use, cystoscopy, prostate surgery and biopsy may affect PSA for a period of time. Conversely, medicines such as finasteride or dutasteride can reduce measured PSA, which is why the prescribing medication and duration of use should always be discussed when reviewing results.

Clinicians may look at the PSA trend, sometimes called PSA velocity, as well as the proportion of free PSA or other blood-based risk tools. If further clarification is needed, a prostate examination, urine testing, multiparametric prostate MRI or a biopsy may be considered. Not every raised PSA requires a biopsy.

Benefits, Limitations and Possible Follow-Up

A potential benefit of PSA screening is that it can help identify some prostate cancers at an earlier stage, when treatment options may be broader. It can also establish a baseline value that may be useful for future comparisons. For people at increased risk, individualized screening discussions may be especially valuable.

Its limitations are equally important. PSA screening can produce false-positive results, meaning the PSA is raised even though cancer is not present. It can also miss some cancers. Further testing may uncover slow-growing cancers that would never have caused symptoms, creating difficult choices about monitoring or treatment.

When results warrant investigation, clinicians may recommend repeat PSA testing, a digital rectal examination, MRI and possibly prostate biopsy. A biopsy can confirm whether cancer cells are present and provide information about their likely behavior, but it has possible complications such as bleeding, infection and temporary urinary discomfort. Decisions should balance the likely benefit of finding clinically important cancer against the burden of testing.

What Is the First Hint of Prostate Cancer?

Early prostate cancer often causes no symptoms. For this reason, an elevated or steadily rising PSA, an abnormal digital rectal examination, or an unexpected finding during evaluation for another concern may be the first hint. Neither a high PSA nor an abnormal examination alone confirms cancer.

When symptoms do occur, they can include a weaker urine stream, difficulty starting urination, needing to urinate more often, waking at night to urinate, blood in urine or semen, or persistent pain in certain situations. These symptoms are much more commonly linked to non-cancer conditions, including prostate enlargement or infection, but they should be assessed by a healthcare professional.

If prostate cancer is diagnosed, the care plan depends on the cancer’s grade, stage, PSA level, imaging findings, general health and personal preferences. Options can include active surveillance, surgery, radiation treatment, hormone therapy and other treatments. Prostate cancer care is individualized, and many people benefit from discussing options with a urology and oncology team.

When to Seek Medical Care

Prompt medical advice is appropriate for blood in the urine, inability to pass urine, fever or chills with urinary pain, severe pelvic pain, unexplained weight loss, or persistent bone pain. These symptoms do not automatically indicate cancer, but they may need timely assessment for infection, obstruction or another condition.

Anyone with a raised PSA result should arrange a follow-up discussion rather than trying to interpret the number alone. A clinician can check for temporary causes, review past results and explain whether repeat testing, examination or referral is appropriate. New or ongoing urinary symptoms also deserve medical review, particularly if they affect daily life.

Acibadem International’s multidisciplinary specialists and JCI-accredited hospitals support international patients who need assessment and treatment for prostate conditions. Care may involve urology, radiology, pathology and oncology professionals when further investigation is appropriate.

Frequently asked questions

Does a high PSA result mean prostate cancer?

No. PSA can be elevated because of benign prostate enlargement, inflammation, infection, ejaculation, recent prostate procedures and other factors. A clinician may recommend repeating the test or arranging further evaluation based on the result and the person’s risk profile.

What PSA level is considered dangerous?

There is no single PSA level that is dangerous or diagnostic of cancer. Higher values may increase the likelihood that further assessment is needed, but the rate of change, age, prostate size, medication use and examination findings are also important.

How long should someone wait to repeat a high PSA test?

The timing depends on the possible reason for the elevated result. A clinician may repeat it after temporary factors such as infection, ejaculation or recent prostate manipulation have resolved, often after several weeks, but the appropriate interval should be individualized.

Can prostatitis raise PSA levels?

Yes. Prostate inflammation and infection can raise PSA, sometimes substantially. Clinicians may evaluate for infection or inflammation and reassess PSA after treatment or recovery before considering more invasive tests.

Can PSA be normal when prostate cancer is present?

Yes. Some prostate cancers occur with PSA values that are within a general reference range. This is one reason why clinicians consider symptoms, examination findings, family history and changes in PSA over time rather than relying on one test alone.

Should PSA screening be done every year?

Not necessarily. Screening intervals depend on age, baseline PSA, overall health, life expectancy, family history and personal preferences. A doctor can help determine whether testing is appropriate and how often it should be repeated.

References

• American Cancer Society
• National Cancer Institute
• European Association of Urology
• American Urological Association
• National Health Service

This article is for general information only and is not a substitute for professional medical advice. Please consult a qualified doctor about your individual situation.